Previous 10 | Next 10 |
2024-03-10 18:35:00 ET More on Assertio Holdings Assertio Holdings: Here's A Contrarian Opportunity In The Health Care Sector Seeking Alpha’s Quant Rating on Assertio Holdings Historical earnings data for Assertio Holdings Financial information for Ass...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 5, 2024) - Faruqi & Faruqi, LLP, a leading national s...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 4, 2024) - Faruqi & Faruqi, LLP, a leading national s...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 3, 2024) - Faruqi & Faruqi, LLP, a leading national s...
LAKE FOREST, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of ...
Philadelphia, Pennsylvania--(Newsfile Corp. - February 29, 2024) - A securities fraud lawsuit has been filed against Assertio Holdings, Inc. ("Assertio") (NASDAQ: ASRT). The lawsuit is captioned Shapiro v. Assertio Holdings, Inc. et al. , No. 1:24cv00169 (N.D. Ill.), and is filed on behalf of pu...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 28, 2024) - Faruqi & Faruqi, LLP, a leading nation...
Do you, or did you, own shares of Assertio Holdings, Inc. (NASDAQ:ASRT)? Did you purchase your shares between March 9, 2023 and November 8, 2023, inclusive? Did you lose money in your investment in Assertio Holdings, Inc.? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE...
RADNOR, PA / ACCESSWIRE / February 27, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been against Assertio Holdings, Inc. ("Assertio") ( NASDAQ:ASRT ). The action charges Assertio with violations of th...
Hagens Berman, National Trial Attorneys, Encourages Assertio Holdings (ASRT) Investors with Substantial Losses to Contact Firm SAN FRANCISCO, CA / ACCESSWIRE / January 24, 2024 / Hagens Berman urges Assertio Holdings, Inc. (NASDAQ:ASRT) investors who suffered substantial losses to submit ...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Urges Assertio Stockholders to Vote Against All Directors at Upcoming Annual Meeting in Order to Either Pressure Current Board to Accept New Stockh...
BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE "AGAINST" DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS PR Newswire Urges Assertio Stockholders to Vote Against All Directors at Upcoming Annual Meeting in Order to Either Pressure ...
LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical compan...